Form 4 for TER Teradyne
Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0000904454-25-000556 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-05 | 2025-11-03 | TER | Turner Michelle L. | CFO | A - Grant | $0.00 | +11.1K | 11.3K | +9,607% | $0 |
| D | 2025-11-05 | 2025-11-03 | TER | Turner Michelle L. | CFO | A - Grant | $0.00 | +9,156 | 9,156 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-03 | A | A | 11,144 | $0.00 | 11,260 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2006 Equity and Cash Compensation Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest in four equal annual installments beginning on November 3, 2026. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-11-03 | A | A | 9,156 | $0.00 | 9,156 | D | $183.07 · — to 2032-11-03 | 9,156 Common Stock | (F2) This option vests 25% per year over four years beginning on November 3, 2026, the first anniversary of the grant. |